The WHO Foundation proudly announces a five-year partnership with the number one cosmetics brand in the world, Maybelline New ...

Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...

One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...

The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.

It’s important to maintain a temperature of 77 degrees or cooler, and above freezing, so efficacy is highest when the product ...

Tokyo, Japan and Cambridge, UK, 23 October 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – is pleased to announce that it has won ...

Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

NEW YORK – Researchers have identified a gene signature that can predict whether early-stage breast cancer patients will ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...